# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Deutsche Bank analyst Emmanuel Papadakis upgrades BioNTech (NASDAQ:BNTX) from Hold to Buy and maintains the price target fro...
- Reuters
TD Cowen analyst Yaron Werber maintains BioNTech (NASDAQ:BNTX) with a Hold and lowers the price target from $98 to $85.
Global markets are experiencing intense volatility, and while it seemed like a Black Monday for Wall Street was inevitable foll...
BioNTech posted a significant Q2 2024 loss of 807.8 million euros. Sales dropped to 128.7 million euros as the demand for COVID...
The stock market is on track to gap-open sharply lower on Monday as negative sentiment seen in the final two sessions of last w...